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Association of Blood Pressure and Fitness
With Levels of Atherosclerotic Risk Markers
Pre-Exercise and Post-exercise
Roland von Känel, Suzi Hong, Meredith A. Pung, and Paul J. Mills
AJH 2007; 20:670–675Background: Physical fitness may attenuate the in-
creased atherosclerotic risk in patients with systemic hy-
pertension. We investigated the association of screening
blood pressure (BP) and cardiorespiratory fitness with
baseline levels and exercise-induced changes in levels of
soluble atherosclerotic risk markers.
Methods: Twenty-six otherwise healthy and unmedi-
cated subjects with elevated BP (systolic BP and/or dia-
stolic BP 130/85 mm Hg) and 40 subjects with normal
BP underwent 20-min treadmill exercise at 65% to 70% of
predetermined peak oxygen consumption (VO2peak). Inter-
leukin (IL)-6, soluble intercellular adhesion molecule
(sICAM)-1, von Willebrand factor (VWF) antigen, and
plasminogen activator inhibitor (PAI)-1 antigen were mea-
sured at baseline (ie, pre-exercise), early postexercise, and
late postexercise (ie, 25 min after exercise).
Results: At baseline, higher screening mean arterial BP
(MAP) independently predicted higher sICAM-1 levels
(P  .031), and lower VO2peak independently predicted
and Behavioral Medicine Program (RvK, SH, MAP, PJM), Department of
0895-7061/07/$32.00
doi:10.1016/j.amjhyper.2007.01.005higher IL-6 (P .016) and PAI-1 (P .001) levels. Early
and late postexercise lower VO2peak was associated with
higher mean PAI-1 (P  .072) and IL-6 (P  .026) levels,
and higher screening MAP was associated with higher
mean sICAM-1 levels (P  .035). Higher VO2peak was
associated with a greater PAI-1 increase from baseline to
early postexercise in subjects with elevated BP (P  .045)
but not in those with normal BP.
Conclusions: Circulating levels of some atheroscle-
rotic risk markers at baseline and with exercise were
higher with elevated BP and lower with better fitness.
Greater fitness did not particularly protect subjects with
elevated BP from potentially harmful responses of athero-
sclerotic risk markers to acute physical exercise. Am J
Hypertens 2007;20:670–675 © 2007 American Journal of
Hypertension, Ltd.
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stasis, hypertension, inflammation.E levated plasma levels of proinflammatory and pro-thrombotic markers contribute to the increased riskof atherosclerosis and atherothrombotic events in
individuals with elevated systemic blood pressure (BP).1,2
Increased cardiorespiratory fitness attenuates the risk of
atherosclerotic cardiovascular diseases.3 Among hyperten-
sive men, physical fitness was inversely associated with
plasma levels of C-reactive protein and soluble intercellu-
lar adhesion molecule (sICAM)-1.4 Atherosclerotic risk
increases linearly with higher BP and moreover is pre-
dicted by both systolic and diastolic BP.5 We therefore
hypothesized that in a sample of subjects with and without
elevated BP, higher mean arterial BP (MAP) and poorer
fitness would show associations with higher plasma base-
line levels of atherosclerotic markers of inflammation and
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tive relationship between MAP and atherosclerotic mark-
ers would be attenuated by good fitness.
In patients with coronary heart disease and hyperten-
sion, short-term strenuous physical activity is a triggering
factor for an acute coronary event commonly initiated by
the rupture of an atherosclerotic plaque.6,7 Subsequently,
an exercise-induced prothrombotic and proinflammatory
milieu may contribute to the rapid growth of a coronary
thrombus.8 Whether fitness affects the exercise-induced
acute change in proatherogenic factors in hypertension has
not been studied. We hypothesized that increases in proin-
flammatory and prothrombotic activity with exercise are
associated with a higher screening MAP and lower fitness
level. We further hypothesized that the positive associa-
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levels of inflammation and thrombogenesis is less pro-
nounced in fit individuals.
To test the above hypotheses, we measured interleukin
(IL)-6, sICAM-1, von Willebrand factor (VWF), and plas-
minogen activator inhibitor (PAI)-1 in plasma. We se-
lected these molecules because they were previously
shown to be increased with elevated BP;9–11 were predic-
tive of first-time myocardial infarction;12–15 and, except
for PAI-1, were responsive to physical exercise.16–19 Also,
they all define paramount processes in atherosclerosis
initiation and progression. Although also having antiin-
flammatory properties, IL-6 is a potent initiator of the
acute-phase response with sympathetic activation.20 Solu-
ble ICAM-1 reflects the endothelial expression of ICAM-1
that facilitates leukocyte transmigration and thereby vas-
cular inflammation.21 The VWF mediates platelet adhe-
sion to endothelial lesions; elevated VWF levels reflect a
procoagulant state and endothelial activation or damage.22
High levels of antifibrinolytic PAI-1 give rise to intravas-
cular fibrin accumulation.23
Materials and Methods
Study Participants and
Screening BP Assessments
This study was approved by the Institutional Review
Board of the University of California at San Diego
(UCSD). We recruited 66 healthy volunteers from the
community who responded to a newspaper advertisement,
other printed material (flyers and pamphlets), or word-of-
mouth referral. All participants provided written, informed
consent to participate in a study on the effects of fitness
and exercise on cardiovascular risk in hypertension. Ex-
clusion criteria included history of heart, liver, or renal
disease; diabetes; severe asthma; psychosis; and current
use of prescribed medication. These were questioned by
self-report during the initial screening visit and verified by
a history and physical examination performed by a li-
censed physician. Current pregnancy was verified by hu-
man chorionic gonadotropin screening, and obesity was
determined by 150% ideal body weight.24 Signs of heart
disease were examined by electrocardiogram (ECG), and
signs of liver or renal disease and diabetes were examined
by laboratory liver, metabolic, and thyroid panels before a
subject’s eligibility was determined. If subjects were tak-
ing antihypertensive medication, this was tapered, fol-
lowed by a 3-week washout period, under close
monitoring of BP throughout the duration of the study to
ensure safety.
Screening BP was measured three times on two sepa-
rate days, using a Dinamap vital signs monitor (model
845XT; Critikon, Inc., Tampa, FL), and the mean was
computed. We applied an appropriately sized cuff and
typically allowed 1 min between readings after subject sat
resting for approximately 10 min. We used either screen-
ing systolic and/or diastolic BP 130/85 mm Hg as thepartition for the designation of hypertension, correspond-
ing to recently published criteria for the definition of “high
normal BP levels.”25 We selected this cutoff because it
yielded two reasonably sized groups of subjects with ei-
ther “normal BP” (n  40) or “elevated BP” (n  26),
allowing us to meaningfully illustrate continuous associa-
tions between MAP and outcome variables.
Exercise Test Procedure
Exercise tests were performed at the UCSD Clinical Trials
Center and Pulmonary Function Laboratory by a certified
cardiopulmonary technician supervised by a physician. To
determine the peak oxygen consumption (VO2peak [mL/
kg/min]), subjects underwent a VO2peak test on a treadmill.
Termination of the test was based on subjects’ indication
that they had reached their maximum capacity. The guide-
lines for verifying obtaining VO2peak, such as perceived
exertion, respiratory exchange ratio 1.0, or peak heart
rate (HR) similar to an age-predicted maximum (220
bpm  age in years), were used to confirm that VO2peak
had been obtained. We applied the standard Bruce proto-
col, where the speed and grade of the treadmill are in-
creased by 1.7 mph and 10%, respectively, every 3 min.
Expired gas was analyzed by use of a Sensormedics met-
abolic cart (Viasys Healthcare Inc., Conshohocken, PA)
equipped with Vmax software (version 6-2A; Viasys
Healthcare Inc., Conshohocken, PA), and ECG leads were
recorded with Marquette CardioSoft version 3 (GE Med-
ical Systems, Milwaukee, WI). Oxyhemoglobin saturation
was monitored with pulse oximetry (Ohmeda; Datex, Lou-
isville, CO). During exercise, BP was assessed by a trained
nurse practitioner using a hand sphygmomanometer.
Approximately 1 week after the VO2peak test, subjects
returned to the laboratory after having abstained from
caffeine, vigorous exercise, alcohol, and smoking for 24 h.
A 19-gauge venous forearm catheter was inserted, fol-
lowed by a supine rest period to establish baseline values
for the ECG and BP. After a warm-up period, 20 min of
exercise were performed on the treadmill at a calculated
(ie, 65–70% VO2peak assessed) steady-state/submaximal
intensity. The VO2 was monitored throughout the steady-
state exercise, to maintain the predetermined intensity, and
the subjective exertion was also monitored by Borg’s
6–20 scale ratings of perceived exertion (RPE). The BP
and RPE were recorded every 3 min during exercise. After
the 20-min treadmill test, there was a 2-min cool-down
phase, during which subjects walked slowly. Blood sam-
ples to assess atherosclerotic markers were obtained with
the subject in supine position at “baseline” (ie, pre-exer-
cise), “early postexercise” (ie, levels immediately after the
20-min exercise bout), and “late postexercise” (ie, levels
25 min after termination of the exercise bout).
Measurement of Atherosclerotic Markers
Whole blood was drawn into Vacutainer tubes (Becton
Dickinson, Franklin Lakes, NJ) containing either EDTA
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3.8% (for the VWF antigen assay), or buffered sodium
citrate supplemented with theophylline, adenosine, and
dipyridamole (CTAD) 3.8% (for the PAI-1 antigen assay).
The EDTA blood and CTAD blood were spun in a refrig-
erated centrifuge for 10 min at 2500  g. Sodium citrate
blood was spun twice at room temperature for 10 min at
3000  g. Plasma aliquots were stored in polypropylene
tubes at 80°C until further analysis. Plasma concentra-
tions of high-sensitivity IL-6 and sICAM-1 (both R&D
Systems, Minneapolis, MN) and of VWF and PAI-1 (both
Asserachrom Stago, Parsippany, NJ) were determined by
ELISA. The lower detection limits of assays were 0.04
pg/mL for IL-6, 0.35 ng/mL for sICAM-1, 1 ng/mL for
PAI-1, and 1% for VWF.
There were missing data as following: one sICAM-1
and VWF and 3 IL-6 and PAI-1 values for baseline levels;
and 6 IL-6 and PAI-1, 5 sICAM-1, and 4 VWF values for
postexercise levels. The intraassay coefficient of variation
(CV) was 5.0% for sICAM-1, 13.0% for IL-6, 3.3% for
VWF, and 4.7% for PAI-1. The interassay CV was 5.6%
for sICAM-1, 8.6% for VWF, and 3.2% for PAI-1. The
interassay CV was not assessed for IL-6 because internal
control samples were unavailable. The CVs were in ac-
cordance with current standards.
Statistical Analyses
Data were analyzed using SPSS version 12.0 for Windows
(SPSS, Inc., Chicago, IL). All tests were two-tailed, with
P  .05. To obtain a normal distribution, IL-6 and VWF
values were logarithmically transformed. Log10-trans-
formed IL-6 and VWF values were used for all analyses.
Data are given as mean  SEM of raw values for
sICAM-1 and PAI-1, and as geometric means (antilog of
the logs’ arithmetic mean)  SEM for IL-6 and VWF. An
independent-samples t-test and Pearson 2 test were ap-
plied to investigate group differences in continuous and
categorical measures, respectively. Pearson correlations
were used to estimate the relationship between 2 contin-
uous variables.
We performed multiple linear regression analyses to
determine the independent predictive value of screening
MAP, VO2peak, and their interaction for baseline (ie, pre-
exercise) levels of each atherosclerotic marker. To build
Table 1. Characteristics in 66 subjects by blood-pr
Variable
Sex (male/female)
Age (y)
Screening mean arterial blood pressure (mm Hg)
Body mass index (kg/m2)
VO2peak (mL/kg/min)VO2peak  peak oxygen consumption during exercise. Analyses were by
* Screening systolic blood pressure and/or diastolic blood pressure the models, we entered the variables’ age, sex, MAP,
VO2peak, and the MAP-by-VO2peak interaction in one
block into the equations. We applied repeated-measures
ANOVA to investigate whether changes in levels of ath-
erosclerotic markers across time points (ie, from baseline
to early postexercise and to late postexercise) were signif-
icant. Repeated-measures ANCOVA was used to investi-
gate the association of screening MAP, VO2peak, and their
interaction with acute exercise responses in atheroscle-
rotic markers adjusted for age and sex. This analysis was
used when several measurements of the same type were
examined on the same subject. Post hoc analysis was
performed to identify the direction of a significant inter-
action between screening MAP and VO2peak, applying
Fisher’s least significant difference. Assumptions of mul-
tiple regression and repeated-measures ANOVA and
ANCOVA were met.
Because all the VO2peak used in our data analyses were
adjusted for body weight (mL/kg/min) rather than absolute
oxygen consumption (L/min), we made no additional ad-
justments for body mass index (BMI). Because the four
atherosclerotic risk markers clearly differ in their biolog-
ical functions, no statistical adjustment for multiple com-
parisons was performed.
Results
Subjects Characteristics
Table 1 presents comparisons of the demographic and car-
diovascular characteristics of the 66 subjects categorized into
the elevated BP versus normal BP groups. Individuals with
elevated BP were older and had a higher BMI compared with
those with normal BP. Partly as a consequence of higher
weight, individuals with elevated BP also had lower VO2peak
(mL/kg/min) than those with normal BP.
Bivariate Associations with
Atherosclerotic Markers at Baseline
Subjects with elevated BP had higher levels of PAI-1
(62.6  7.4 ng/mL v 39.5  5.4 ng/mL; P  .013) and
sICAM-1 (283.8 18.3 ng/mL v 245.3 9.1 ng/mL; P
.043) than the normal BP group. Accordingly, MAP cor-
related with PAI-1 (r  0.30, P  .017) and with
sICAM-1 (r  0.36, P  .003). Although showing a
re categorization
levated blood
ssure* (n  26)
Normal blood
pressure (n  40) P value
15/11 19/21 .418
46.7  1.5 33.7  1.4 .001
106  2 85  1 .001
28.4  0.8 24.4  0.7 .001
30.6  1.9 37.5  1.4 .004
2essu
E
preStudents t-test or Pearson  test. Values are mean  SEM.
130 mm Hg or 85 mm Hg.
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elevated BP than in those with normal BP, the differences
in IL-6 (0.99  0.13 pg/mL v 0.75  0.10 pg/mL; P 
.15, d  0.39) and in VWF (130.2%  9.8% v 111.0% 
7.6%; P  .12, d  0.41) between BP groups were not
significant.
The VO2peak showed inverse correlations with IL-6
(r  0.31, P  .015) and with PAI-1 (r  0.34, P 
.007). The VO2peak also showed a trend toward statistical
significance for an inverse correlation with sICAM-1 (r 
0.24, P .056) but was not significantly associated with
VWF.
Independent Predictors of
Atherosclerotic Markers at Baseline
Table 2 shows that physical fitness was inversely associ-
ated with levels of PAI-1 (P  .001) and IL-6 (P  .016)
and that MAP was directly associated with levels of
sICAM-1 (P  .031). More precisely, for a 1 mL/kg/min
decrease in VO2peak, there were mean increases in PAI-1
of 2.1  0.5 ng/mL, and in IL-6 of 0.03  0.01 pg/mL.
Also, there was a mean increase of 2.1  0.9 ng/mL in
sICAM-1, with a 1 mm Hg increase in MAP. In addition,
male sex was significantly predictive of higher PAI-1 (P
.001). Age and the interaction between MAP and VO2peak
Table 2. Multiple linear regression analyses of bas
Predictors
entered IL-6 (pg/mL) sICAM-1
Sex 0.16 (0.31/0.15) 5.50 (4
Age (y) 0.01 (0.05/0.05) .53 (3
MAP (mm Hg) 0.01 (0.01/0.03) 2.05 (0.2
VO2peak
(mL/kg/min) 0.03 (0.04/0.01)† 1.47 (3
Interaction term 0.00 (0.00/0.00) 0.10 (0
IL-6  interleukin-6; interaction term  MAP-by-VO2peak interactio
inhibitor; sICAM-1  soluble intercellular adhesion molecule-1; VW
Dummy coding of 0 and 1 was used for men and women, respe
(slope) with 95% confidence interval (lower limit/upper limit). Th
variable (ie, each atherosclerotic risk marker) changes when the p
constant. Coefficients with confidence intervals are given in raw va
* P  .001; † P  .05.
Table 3. Change in atherosclerotic risk marker lev
Marker Baseline Early po
IL-6 (pg/mL) 0.83  0.08 1.11
sICAM-1 (ng/mL) 259.9  9.8 278.1
VWF (%) 120.2  6.3 119.1
PAI-1 (ng/mL) 49.1  4.8 50.5
Data are given as mean  SEM for sICAM-1 and PAI-1 and as geome
(IL)-6 and plasminogen activator inhibitor (PAI)-1, n  61 for so
Willebrand factor (VWF). A significant P value for repeated-measur
ercise and to late postexercise values. Post hoc comparisons were
points.
* P  0.001 and † P  0.01, compared with values at baseline; ‡ P were not independent predictors of any atherosclerotic
marker at baseline (all P  .10).
Metabolic Responses to 20-Min Exercise
During 20 min of steady-state exercise, the mean MAP
was higher in individuals with elevated BP than in normal
BP individuals (120  2 mm Hg v 96  2 mm Hg; P 
.001). At the end of the exercise test, the mean respiratory
exchange ratio (1.15  0.1 v 1.14  0.1; P  .80) and
percent heart rate (HR) of the age-predicted maximum HR
(97.1%  1.6% v 95.2%  1.5%; P  .42) were similar
in the elevated and normal BP groups. Both groups simi-
larly perceived their mean exertion during the 20-min
exercise period as “somewhat hard” (elevated BP group
13.2  0.3, normal BP group  13.2  0.3; P  .99),
indicative of moderate exertion, which was consistent
throughout the exercise period.
Atherosclerotic Marker
Responses to 20-Min Exercise
In all subjects, repeated-measures ANOVA showed that
crude changes across time points were significant for IL-6,
sICAM-1, and VWF but not for PAI-1 (Table 3). The
following repeated-measures analyses were all adjusted
for age and sex (ANCOVA).
levels of atherosclerotic risk markers
/mL) VWF (%) PAI-1 (ng/mL)
35.5) 13.1 (30.9/11.0) 38.0 (55.3/20.7)*
1.99) 0.55 (1.08/2.18) .80 (1.84/0.23)
.91)† 0.28 (0.81/1.63) 0.50 (0.26/1.26)
0.90) 0.26 (1.87/1.08) 2.09 (3.07/1.11)*
0.15) 0.17 (0.18/0.30) 0.05 (0.10/0.01)
P  mean arterial blood pressure; PAI-1  plasminogen activator
on Willebrand factor.
ly, for sex. Columns show unstandardized regression coefficient b
ression coefficient b designates the mean amount the dependent
tor variable changes by one unit and the other predictors are held
or sICAM-1 and PAI-1 and in antilog values for IL-6 and VWF.
ith exercise across all subjects
ercise Late postexercise P (ANOVA)
.10* 1.33  0.12*‡ .001
.9* 258.9  9.9‡ .001
.0 102.3  7.6†§ .015
.7 46.5  3.6 .48
ean SEM for IL-6 and VWF. Sample sizes are n 60 for interleukin
intercellular adhesion molecule (sICAM)-1, and n  62 for von
OVA indicates a significant change from baseline to early postex-
to examine differences in marker values between individual timeeline
(ng
6.5/
.06/
0/3
.85/
.13/
n; MA
F  v
ctive
e reg
redic
lues fels w
stex
 0
 9
 8
 3
tric m
luble
es AN
made0.001 and § P  0.05, compared with values at early postexercise.
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ated with mean IL-6 at all time points (P  .012, effect
size/partial eta squared [p2]  0.11). Mean VO2peak
showed inverse associations with mean IL-6 at baseline
(0.82  0.08 pg/mL; r  0.31, P  .020), early pos-
texercise (1.11  0.10 pg/mL; r  0.31, P  .019), and
late postexercise (1.34  0.34 pg/mL; r  0.30, P 
.026).
Soluble ICAM-1 Mean screening MAP was signifi-
cantly associated with mean sICAM-1 levels at all time
points (P  .011, p2  0.11). Mean screening MAP
showed direct associations with mean sICAM-1 at base-
line (259.8  9.8 ng/mL; r  0.28, P  .035), early
postexercise (277.9  9.9 ng/mL; r  35, P  .007), and
late postexercise (256.9  9.7 ng/mL; r  0.35, P  .008).
The interaction between MAP and VO2peak showed a
significant association with an exercise-induced change in
sICAM-1 across all time points (P  .047, p2  0.07).
Across all time points, the association between VO2peak
and change in sICAM-1 was significant in subjects with
normal BP (P  .024, p2  0.15) but not in those with
elevated BP (P  .86, p2  0.01). However, associations
between VO2peak and increase in sICAM-1 from baseline
to early postexercise (20.8  5.1 ng/mL; P  .15) and
between VO2peak and decrease in sICAM-1 from early to
late postexercise (19.8  4.0 ng/mL; P  .23) were not
significant in the normal BP group.
Plasminogen Activator Inhibitor-1 Mean VO2peak was
significantly associated with mean PAI-1 levels at all time
points (P  .001, p2  0.18). Mean VO2peak showed
inverse associations with mean PAI-1 levels at baseline
(47.3  4.0 ng/mL; r  0.48, P  .001), early postex-
ercise (50.0  3.4 ng/mL; r  0.36, P  .006), and, at
borderline significance, late postexercise (47.2 3.5 ng/mL;
r  0.24, P  .072).
The MAP-by-VO2peak interaction showed a significant
association with exercise-induced change in PAI-1 across all
time points (P  .004, p2  0.15). Across all time points,
VO2peak was significantly associated with exercise-induced
change in PAI-1 in subjects with elevated BP (P  .004,
p
2  0.35) but not in those with normal BP (P  .73,
p
2  0.01). In subjects with elevated BP, there was a
significant increase of 1.3  0.6 ng/mL (P  .045) in
PAI-1 from baseline to early postexercise, with one unit of
increase in VO2peak.
von Willebrand Factor Exercise-induced changes in
VWF levels across all time points and mean VWF levels
at all three time points were similar in subjects with
different levels of MAP and VO2peak.
Discussion
We found that MAP was an independent predictor of
baseline sICAM-1 and that fitness was an independent
predictor of baseline IL-6 and PAI-1. These findings are
consistent with the notion that proinflammatory and pro-thrombotic changes might link poor physical fitness with
increased cardiovascular disease mortality over the long
term.3,26,27 Our findings may have clinical relevance. The
risk of first-time myocardial infarction was previously
increased with increasing quartiles of IL-6 and sICAM-1
concentrations.12,13 In our group of individuals, second-
to-third and third-to-fourth quartile transitions in sICAM-1
levels corresponded with MAP increases of 15 and 18 mm
Hg, respectively. Transitions between the second-to-third
and third-to-fourth quartiles in IL-6 levels corresponded
with decreases in VO2peak of 13 and 18 mL/kg/min, re-
spectively.
Greater fitness did not mitigate the positive relationship
between MAP and sICAM-1, suggesting that reduction in
inflammation and thrombogenicity occurs with better car-
diorespiratory fitness, regardless of BP in our sample. As
our groups of individuals had relatively mildly elevated
BP, it is possible that this effect of fitness on BP–athero-
sclerotic marker associations is greater in individuals with
severe hypertension. The question remains as to whether a
healthy lifestyle, in addition to improving fitness, might
help retrain proinflammatory and prothrombotic activity in
subjects with elevated BP.
Acute exercise induced significant responses in all sub-
jects in IL-6, sICAM-1, and VWF but not in PAI-1 antigen.
Higher MAP was associated with higher sICAM-1, and
better fitness was associated with lower IL-6 and PAI-1 at
early and late postexercise. Postexercise associations were
primarily due to associations of MAP and fitness with
baseline levels of atherosclerotic markers. Although MAP
and fitness were not individually associated with the mag-
nitude of exercise-induced changes in atherosclerotic
markers, there was interaction between MAP and fitness.
Contrary to our hypotheses, the interaction between MAP
and fitness for sICAM-1 was significant in normotensive
subjects, and higher fitness was associated with a PAI-1
increase in hypertensive subjects, suggesting possibly in-
creased cardiovascular risk.23
Given the mixed findings in previous studies, these
rather unexpected findings should be interpreted with cau-
tion. For instance, the VWF response to exercise increased
with physical conditioning28 and was also greater in phys-
ically fit than in sedentary individuals.29 Instead of infer-
ring cardiovascular harm, previous investigators proposed
that fitness might physiologically increase endothelial
turnover,29 thereby enhancing the endothelial release of
VWF and endothelial antifibrinolytic properties.28 Unfor-
tunately, we did not measure indicators of fibrinolytic
activity above and beyond PAI-1 antigen. Information on the
activities of tissue-type plasminogen activator and PAI-1
could have created a more definite picture of overall fibrino-
lytic activity in our study.30 Because fitness was also not
significantly associated with greater exercise responses in
VWF, sICAM-1, and IL-6, we offer a careful interpretation of
our exercise data. In spite of good fitness, subjects with
elevated BP may not necessarily be protected from short-
term, exercise-induced hypercoagulability, a possible con-
675AJH–June 2007–VOL. 20, NO. 6 BLOOD PRESSURE, FITNESS, AND ATHEROSCLEROTIC RISK MARKERStributing factor to the clinical manifestation of acute coronary
thrombosis as triggered by exercise bouts.8
Our study had several strengths and limitations. Sub-
jects were in good health and unmedicated, so that con-
founding of levels of atherosclerotic markers was
minimized. Moreover, cardiovascular fitness was assessed
by a standardized method. However, a retrospective power
analysis showed that the differences in baseline IL-6 and
VWF levels between BP groups and the association be-
tween VO2peak and baseline sICAM-1 in all subjects
would only have been statistically significant if we had
roughly doubled the sample size. We did not use 24-h BP
monitoring to approximate the “real” screening BP, and
subjects were not explicitly instructed to refrain from
alcohol and coffee before BP screening, so a bias in MAP
measurements could have influenced our results. Our find-
ings may not generalize to subjects with more severe
hypertension, elderly hypertensive patients, and hyperten-
sive patients with very poor physical fitness.
In conclusion, we found independent associations of
higher screening MAP and poorer physical fitness with
higher baseline levels of markers of a proinflammatory and
prothrombotic state. The exaggerated increase in PAI-1 from
baseline to early postexercise in physically fit hypertensive
subjects suggests that fitness alone may not readily protect
those with elevated screening BP from potentially harmful
cardiovascular responses to exercise.
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